Topiramate-associated worsening symptoms in a patient with familial hemiplegic migraine

Journal of the Neurological Sciences

Volumn 272, Issue 1-2, 2008, Pages 194-195

  Striano, Pasquale ^a,b   Zara, Federico ^b   Santorelli, Filippo Maria ^c   Striano, Salvatore ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b G GASLINI INSTITUTE   (Italy)

^c BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

Adverse effect; Hemiplegic migraine; Topiramate

Indexed keywords

ACETAZOLAMIDE; TOPIRAMATE;

ADULT; ARTICLE; CASE REPORT; DISEASE EXACERBATION; DISORIENTATION; DRUG WITHDRAWAL; DYSPHASIA; FAMILIAL HEMIPLEGIC MIGRAINE; FEMALE; FOOT PARAESTHESIA; HUMAN; PARESTHESIA; PRIORITY JOURNAL;

ADULT; DISEASE PROGRESSION; FRUCTOSE; HUMANS; MALE; MIGRAINE WITH AURA; NEUROPROTECTIVE AGENTS;

EID: 48349142756     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2008.05.015     Document Type: Article

References (5)

1. Silberstein S.D., Neto W., Schmitt J., Jacobs D., and MIGR-001 Study Group. Topiramate in migraine prevention: results of a large controlled trial. Arch Neurol 61 (2004) 490-495
2. D'Amico D. Antiepileptic drugs in the prophylaxis of migraine, chronic headache forms and cluster headache: a review of their efficacy and tolerability. Neurol Sci 28 Suppl 2 (2007) S188-197
3. Rozen T.D. Worsening of headaches on topiramate? A low cerebrospinal fluid pressure syndrome?. Headache 43 (2003) 819-820
4. Headache Classification Committee of the International Headache Society. International Classification of Headache Disorders. 2nd edition. Cephalalgia vol. 24 (2004) 1-160
5. Shank R.P., Doose D.R., Streeter A.J., and Bialer M. Plasma and whole blood pharmacokinetics of topiramate: the role of carbonic anhydrase. Epilepsy Research 63 (2005) 103-112